Skip to content
MarketScale
‹ Back to IndustriesSciences

The Differences Between Calendered and Extruded Vinyl Films

There are two main ways to produce vinyl films: calendering and extrusion. Each of these industrial processes can be used to produce a range of film and sheet products with distinct qualities. As with any manufacturing process, there are advantages and disadvantages to each approach. What is Calendering? In calendering, raw materials enter a mixing…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Promoted Content · Promoted Content
Share
The Differences Between Calendered and Extruded Vinyl Films

Key takeaways

01

There are two main ways to produce vinyl films: calendering and extrusion.

02

Each of these industrial processes can be used to produce a range of film and sheet products with distinct qualities.

03

As with any manufacturing process, there are advantages and disadvantages to each approach.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Start free

There are two main ways to produce vinyl films: calendering and extrusion. Each of these industrial processes can be used to produce a range of film and sheet products with distinct qualities. As with any manufacturing process, there are advantages and disadvantages to each approach.

What is Calendering?

In calendering, raw materials enter a mixing chamber where they are melted. This molten plastic then moves through a series of heated rollers that compress the material to the desired thickness. Finally, it passes through a series of surface conditioning and cooling rolls, then is wound into custom rolls or cut into sheets.

Calendering Pros and Cons

On the plus side, calendering allows high run rates on films 6 to 60 mils thick. Calendered material typically has higher tensile properties, product uniformity, and unusually close gauge control when compared with extruded films. The added mixing in the process is ideal for highly filled applications and materials, and has the additional advantage that melt degassing occurs in the process. Finally, materials with lower melt temperatures can be used in calendering due to the high pressures used between rollers.

On the downside, calendered products may have issues with pinholes at gauges less than 6 mils, and there may be appearance issues. The rollers used may create surface blemishes and edge buildup on the melt path can create black specs. Also, the sheets are usually less glossy than extruded materials. Calendering is a process that is typically not economically profitable for short production runs.

What is Extrusion?

In extrusion, mixed plastic compound is conveyed through a heated barrel using a spiral shaped screw, converting it into molten plastic. A lip die flattens the mass into a sheet of the desired width and thickness, which then passes through heated embossing rolls that impart a surface finish. The sheet is then trimmed to its final dimension.

Extrusion Pros and Cons

Extrusion offers a number of advantages. Even at thinner gauges, extruded film is pinhole free and has improved “lay flat” qualities. The extrusion process is more flexible, allowing faster changeovers for smaller production runs. The process also delivers better dimensional stability in both machine and cross web directions, and screws can be designed for specific formulations to help improve film characteristics. Finally, the streamlined melt flow reduces black specks.

A disadvantage of extrusion is the requirement for higher melt temperatures. There can also be poor mixing on highly filled formulations. Finally, melt degassing can be a production issue.

Presco Uses Extrusion to Produce Its Presco Engineered Film

Presco compounds and extrudes the flexible vinyl film known as Presco Engineered Film, which is custom formulated to the exact specification of our customers. And in 2017, Presco added Ethylene Vinyl Acetate (EVA) film extrusion to its capabilities as an option for PVC-free manufacturing. To learn about our capabilities, click here.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

PC
Promoted Content

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Sciences Insights

Pharma supplier diversification means little if every supplier uses the same airport

Pharma supplier diversification means little if every supplier uses the same airport

Biocair's Patrick Wohl argues in Pharmaceutical Commerce that life sciences firms must map airports, sea lanes, customs gateways and carriers alongside suppliers. Suppliers spread across countries can still share one air hub. The fix he describes is pre-qualified alternate routes and continuous review, with clinical trial shipments and cold-chain medicines the first cargo exposed when a corridor closes.

  • 01A supplier base spread across several countries can still be a single point of failure if every shipment routes through one airport hub or corridor; the sharper question for a logistics provider is which hubs each qualified lane actually depends on.
  • 02Gartner data cited by MD+DI gives a benchmark: 42% of procurement leaders rank supply disruption as their organization's top risk, with geopolitical issues including tariffs and regulatory changes ranking third.
  • 03A route map ages fast. Pharmaceutical Commerce published the mapping argument on July 24 and was reporting fresh Red Sea and Iran-related freight risk for pharma lanes by Aug. 10, which is the case for treating mapping as a recurring review rather than a project.

Sep 17, 2026

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS Materials and Yokogawa ran an autonomous AI controller on a butadiene distillation column for 35 days and cut steam use 40%. It’s a real operations proof point. It also puts integration and governance gaps front and center.

  • 01A 35-day closed-loop run is a stronger autonomy proof point than a demo, it forces plants to prove handover, fallback, and KPIs over real feed and operating swings.
  • 02Steam reduction claims are compelling, but procurement and ops teams should pin vendors to baselines, operating envelopes, and how off-spec avoidance is measured.
  • 03Agentic AI is showing up as “work management” and “shift checklist” agents before it replaces control engineers, which shifts requirements toward clean, permissioned data access.

Sep 13, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

PC
Promoted Content

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512